COVID-19 Prophylaxis. COVID-19, virus not identified
Conditions
Interventions
Intervention 1: Intervention group 1: Three puffs of FLOVAR® spray on each side, equivalent to a total of 500µl of medicine, once a week and receiving an additional dose of medicine in case of contact
Sponsors
Hakiman e Shargh Research Co.
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Age 18 years and older Informed consent
Exclusion criteria
Exclusion criteria: History of moderate or severe asthma Participating in another clinical trial for COVID-19
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of COVID-19 infection. Timepoint: Time Frame: 14-20 months after admission to the study. Method of measurement: Acquisition of COVID-19 infection as confirmed by positive PCR swab taken 3-5 days after symptom onset. | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration and intensity of COVID-19 symptoms of infected participants. Timepoint: Two weeks after onset of disease symptoms. Method of measurement: Questionnaire of symptoms, duration and intensity of disease.;Side effects of intervention. Timepoint: Duration of Study. Method of measurement: Questionnaire of side effects. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactLeila Safaeian
Esfahan University of Medical Sciences
Outcome results
None listed